Erin E Rowell1, Kristine S Corkum2, Timothy B Lautz2, Monica M Laronda3, Amy L Walz4, Mary Beth Madonna2, Barbara A Lockart5, Marleta Reynolds2. 1. Department of Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, USA; Division of Pediatric Surgery, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA. Electronic address: erowell@luriechildrens.org. 2. Department of Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, USA; Division of Pediatric Surgery, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA. 3. Division of Pediatric Surgery, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA; Stanley Manne Children's Research Institute, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA; Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. 4. Division of Hematology, Oncology, and Stem Cell Transplantation, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA. 5. Division of Pediatric Surgery, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA; Division of Hematology, Oncology, and Stem Cell Transplantation, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA.
Abstract
BACKGROUND/ PURPOSE: Many survivors of childhood cancer will experience premature gonadal insufficiency or infertility as a consequence of their medical treatments. Ovarian tissue cryopreservation (OTC) remains an experimental means of fertility preservation with few reports focused on the surgical technique and postoperative outcomes for OTC in children. METHODS: This is a single institution, retrospective review of OTC cases from January 2011 to December 2017. Children were eligible for OTC if they had a greater than 80% risk of premature ovarian insufficiency or infertility owing to their anticipated gonadotoxic medical treatment. RESULTS: OTC was performed in 64 patients. Median age was 12 years old (range: 5 months-23 years). Nearly half (48%) of the patients were premenarchal. Laparoscopic unilateral oophorectomy was performed in 84% of patients. There were no surgical complications. In 76% of patients, OTC was performed in conjunction with an ancillary procedure. The majority (96%) of patients were discharged within 24 hours. Median time from operation to medical therapy was six days, with no unanticipated treatments delays attributable to OTC. CONCLUSIONS: Laparoscopic unilateral oophorectomy for OTC can be performed safely, in combination with other ancillary procedures, as an outpatient procedure without delaying medical therapy for children facing a fertility-threatening diagnosis or treatment. LEVEL OF EVIDENCE: IV.
BACKGROUND/ PURPOSE: Many survivors of childhood cancer will experience premature gonadal insufficiency or infertility as a consequence of their medical treatments. Ovarian tissue cryopreservation (OTC) remains an experimental means of fertility preservation with few reports focused on the surgical technique and postoperative outcomes for OTC in children. METHODS: This is a single institution, retrospective review of OTC cases from January 2011 to December 2017. Children were eligible for OTC if they had a greater than 80% risk of premature ovarian insufficiency or infertility owing to their anticipated gonadotoxic medical treatment. RESULTS: OTC was performed in 64 patients. Median age was 12 years old (range: 5 months-23 years). Nearly half (48%) of the patients were premenarchal. Laparoscopic unilateral oophorectomy was performed in 84% of patients. There were no surgical complications. In 76% of patients, OTC was performed in conjunction with an ancillary procedure. The majority (96%) of patients were discharged within 24 hours. Median time from operation to medical therapy was six days, with no unanticipated treatments delays attributable to OTC. CONCLUSIONS: Laparoscopic unilateral oophorectomy for OTC can be performed safely, in combination with other ancillary procedures, as an outpatient procedure without delaying medical therapy for children facing a fertility-threatening diagnosis or treatment. LEVEL OF EVIDENCE: IV.
Authors: Chiara Perono Biacchiardi; Luisa Delle Piane; Marco Camanni; Francesco Deltetto; Elena Maria Delpiano; Gian Luigi Marchino; Gianluca Gennarelli; Alberto Revelli Journal: Reprod Biomed Online Date: 2011-07-27 Impact factor: 3.828
Authors: Leena Nahata; Teresa K Woodruff; Gwendolyn P Quinn; Lillian R Meacham; Diane Chen; Leslie C Appiah; Courtney Finlayson; Kyle E Orwig; Monica M Laronda; Erin E Rowell; Antoinette Anazodo; Olivia Frias; Julie Sroga Rios; Stacy Whiteside; Veronica Gomez-Lobo; Maggie Dwiggins; Krista J Childress; Holly R Hoefgen; Jennifer M Levine; Yasmin Jayasinghe; Molly Moravek Journal: J Assist Reprod Genet Date: 2020-06 Impact factor: 3.412
Authors: Erin E Rowell; Timothy B Lautz; Krista Lai; Erica M Weidler; Emilie K Johnson; Courtney Finlayson; Kathleen van Leeuwen Journal: Semin Pediatr Surg Date: 2021-09-04 Impact factor: 1.900
Authors: Teresa K Woodruff; Lauren Ataman-Millhouse; Kelly S Acharya; Teresa Almeida-Santos; Antoinette Anazodo; Richard A Anderson; Leslie Appiah; Joy Bader; Kerri Becktell; Robert E Brannigan; Lesley Breech; Maria T Bourlon; Žana Bumbuliene; Karen Burns; Lisa Campo-Engelstein; Jacira R Campos; Grace M Centola; Mauricio Barbour Chehin; Diane Chen; Michel De Vos; Francesca E Duncan; Ahmed El-Damen; Douglas Fair; Yemi Famuyiwa; Patricia Y Fechner; Paula Fontoura; Olivia Frias; Sabrina A Gerkowicz; Jill Ginsberg; Clarisa R Gracia; Kara Goldman; Veronica Gomez-Lobo; Brent Hazelrigg; Michael H Hsieh; Luis R Hoyos; Alfonso Hoyos-Martinez; Robert Jach; Jacek Jassem; Murid Javed; Yasmin Jayasinghe; Roohi Jeelani; Jacqueline S Jeruss; Nalini Kaul-Mahajan; Jessica Keim-Malpass; Tyler G Ketterl; Mohamed Khrouf; Dana Kimelman; Atsuko Kusuhara; William H Kutteh; Monica M Laronda; Jung Ryeol Lee; Vicky Lehmann; Joseph M Letourneau; Lynda K McGinnis; Eileen McMahon; Lillian R Meacham; Monserrat Fabiola Velez Mijangos; Molly Moravek; Leena Nahata; George Moses Ogweno; Kyle E Orwig; Mary Ellen Pavone; Fedro Alessandro Peccatori; Romina Ileana Pesce; Hanna Pulaski; Gwendolyn Quinn; Ramiro Quintana; Tomas Quintana; Bruno Ramalho de Carvalho; Rosalind Ramsey-Goldman; Joyce Reinecke; Fernando M Reis; Julie Rios; Alice S Rhoton-Vlasak; Kenny A Rodriguez-Wallberg; Cassandra Roeca; Seth J Rotz; Erin Rowell; Mahmoud Salama; Amanda J Saraf; Anibal Scarella; Tara Schafer-Kalkhoff; Deb Schmidt; Suneeta Senapati; Divya Shah; Ariella Shikanov; Margarett Shnorhavorian; Jodi L Skiles; James F Smith; Kristin Smith; Fabio Sobral; Kyle Stimpert; H Irene Su; Kouhei Sugimoto; Nao Suzuki; Mili Thakur; David Victorson; Luz Viale; Wendy Vitek; W Hamish Wallace; Ellen A Wartella; Lynn M Westphal; Stacy Whiteside; Lea H Wilcox; Christine Wyns; Shuo Xiao; Jing Xu; Mary Zelinski Journal: J Assist Reprod Genet Date: 2021-01-06 Impact factor: 3.412